BioNTech’s willingness to significantly increase its upfront bet on BNT327 reflects a belief the candidate could set a new ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...

Can-Fite BioPharma (CANF) has released an update. Can-Fite BioPharma has achieved a significant milestone by dosing the first patient in its Phase IIa clinical trial for advanced pancreatic cancer, ...

A molecule in lizard saliva may make it easier to find certain tumors in the pancreas.

Pelareorep has demonstrated “promising” results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer, the company says. It acts by inducing anti ...

The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...